Product Information

ROSUVASTATIN CALCIUM 5 MG TAB is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0333 per EA under NDC 50228011605. Its NADAC has been published 124 times since Apr 10, 2024.

FDA first approved this application on Apr 24, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROSUVASTATIN CALCIUM 5 MG TAB

Rosuvastatin
$0.0333per EA

Strength

5 mg/1

NDC

50228011605

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ROSUVASTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA206381

FDA Approved

4/24/2019

TE Code

AB

On Market Since

4/24/2019

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has been published 124 times since Apr 10, 2024, and over the history we have for it it has declined 28.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0333 per EA
All-time high$0.0468 (Apr 10, 2024)
All-time low$0.0333 (Aug 19, 2026)
52-week high$0.0389
52-week low$0.0333
Median price$0.0377
Average price$0.0378
Largest weekly change+19.5% (Aug 21, 2024)
Weeks tracked124
Tracking sinceApr 10, 2024

Price History

1W

-2.0%

1M

-2.0%

3M

-4.7%

6M

-2.5%

1Y

-14.5%

3Y

N/A

5Y

N/A

All

-28.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ROSUVASTATIN CALCIUM 5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 5 MG TAB, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0333 per EA (NDC 50228011605), effective Aug 19, 2026.

How has the price of ROSUVASTATIN CALCIUM 5 MG TAB changed over time?

Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has declined 28.9%. It has been tracked across 124 weekly CMS publications since Apr 10, 2024.

What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 5 MG TAB?

Since Apr 10, 2024, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has ranged from a low of $0.0333 (Aug 19, 2026) to a high of $0.0468 (Apr 10, 2024), with a median of $0.0377 per EA.

Are there cheaper alternatives to ROSUVASTATIN CALCIUM 5 MG TAB?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROSUVASTATIN CALCIUM 5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures ROSUVASTATIN CALCIUM 5 MG TAB?

ROSUVASTATIN CALCIUM 5 MG TAB (NDC 50228011605) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.